Supplementary Table 4.

Interaction of Alcoholic Liver Disease and Decompensated Cirrhosis/HCC With the Risk for All-Cause Mortality/Mortality due to COVID-19

	Univariate model	Multivariable model
	P for interaction	P for interaction
All-cause mortality
Alcoholic liver disease∗decompensated cirrhosis	.033	.278
Alcoholic liver disease∗HCC	.976	.771
Mortality due to COVID-19
Alcoholic liver disease∗decompensated cirrhosis	.044	.225
Alcoholic liver disease∗HCC	.640	.531

NOTE. Multivariate model for all-cause mortality was adjusted for age, gender, race/ethnicity, etiology of chronic liver disease, decompensated cirrhosis, HCC, diabetes, hypertension, cardiovascular disease, COPD, smoking status, alcohol consumption, and the interaction term (alcoholic liver disease∗decompensated cirrhosis or alcoholic liver disease∗HCC). Multivariate model for mortality due to COVID-19 was adjusted for age, gender, race/ethnicity, etiology of chronic liver disease, decompensated cirrhosis, HCC, diabetes, hypertension, cardiovascular disease, COPD, smoking status, and the interaction term (alcoholic liver disease∗decompensated cirrhosis or alcoholic liver disease∗HCC).

COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; HCC, hepatocellular carcinoma.